PARP1 and diabetes mellitus: Therefore, PARP inhibitors and their derivatives appear to be one of the promising therapeutic approaches for diabetes treatment, although some toxic effects such as reversible liver toxicity,273) teratogenicity,274) growth-retardation,275) and oncogenicity35,36,276) were reported in animal models at very high doses of the inhibitor.